Tecan Group Ltd. announced sales results for 2016. Tecan generated sales of CHF 506 million.

The company also announced that a succession process for the Board of Directors has been initiated. Rolf Classon member of the Board and Chairman since 2009, and Gérard Vaillant member of the Board since 2004, will not stand for re-election at the ordinary Annual General Meeting on April 17, 2018. Dr. Lukas Braunschweiler and Dr. Daniel R. Marshak will be proposed for election as new members. As the successor of Rolf Classon, Dr. Lukas Braunschweiler will be proposed for election as Chairman of the Board of Directors. Dr. Lukas Braunschweiler is CEO of Sonova Holding AG since 2011 and will remain in his role until end of March 2018. He has already been a member of the Board of Directors of the Tecan Group and Chairman of the Audit Committee, from 2009 until 2012. Dr. Daniel R. Marshak is an experienced executive in the life sciences, diagnostics and biopharmaceuticals industries, leading high technology, global businesses and R&D functions for more than 20 years. From 2006 to 2014 he worked at PerkinElmer Inc.